Bench to bedside: new approaches to the immunotherapy of uveitic disease

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

Jabs, D. A., Rosenbaum, J. T., Foster, C. S., Holland, G. N., Jaffe, G. J., Louie, J. S., Nussenblatt, R. B., Stiehm, E. R., Tessler, H. H., Gelder, R. N. V., et al. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00659-0 · Cited by 992 · see citing works

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

Vincenti, F., Kirkman, R. L., Light, S. E., Bumgardner, G. L., Pescovitz, M. D., Halloran, P. F., Neylan, J. F., Wilkinson, A. H., Ekberg, H., Gaston, R. S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380304 · Cited by 861 · see citing works

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 738 · see citing works

A humanized antibody that binds to the interleukin 2 receptor.

Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., & Waldmann, T. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10029 · Cited by 627 · see citing works

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis

Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., & Hafler, D. A. (1993) · Science · doi:10.1126/science.7680493 · Cited by 583 · see citing works

Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent

Chase, M. W. (1946) · Experimental Biology and Medicine · doi:10.3181/00379727-61-15294p · Cited by 504 · see citing works

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.

Higgins, P. J., & Weiner, H. L. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.2.440 · Cited by 406 · see citing works

T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.

Caspi, R. R., ROBERGE, F. G., McAllister, C. G., el-Saied, M., Kuwabara, T., Gery, I., Hanna, E. E., & Nussenblatt, R. B. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.3.928 · Cited by 358 · see citing works

Birdshot Retinochoroidopathy Associated with Hla-A29 Antigen and Immune Responsiveness to Retinal S-Antigen

Nussenblatt, R. B., Mittal, K. K., Ryan, S. J., et al. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90069-1 · Cited by 352 · see citing works

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

Nagler‐Anderson, C., Bober, L. A., Robinson, M. E., Siskind, G. W., & Thorbecke, G. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7443 · Cited by 350 · see citing works

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function.

Daynes, R. A., Araneo, B. A., Dowell, T., Huang, K. L., & Dudley, D. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.979 · Cited by 343 · see citing works

Human Colonic Microbiota: Ecology, Physiology and Metabolic Potential of Intestinal Bacteria

Macfarlane, G. T., & Macfarlane, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1997.11720708 · Cited by 342 · see citing works

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

Bitar, D. M., & Whitacre, C. C. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90305-x · Cited by 289 · see citing works

Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.

Nussenblatt, R. B., Caspi, R. R., Mahdi, R., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1689 · Cited by 281 · see citing works

TREATMENT OF INTRAOCULAR INFLAMMATORY DISEASE WITH CYCLOSPORIN A

Nussenblatt, R. B., Rook, A. H., Wacker, W. B., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90230-1 · Cited by 233 · see citing works

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

Nussenblatt, R. B., Rodrigues, M. M., Wacker, W. B., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110138 · Cited by 171 · see citing works

Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial

Nussenblatt, R. B., Gery, I., Weiner, H. L., et al. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71070-0 · Cited by 152 · see citing works

Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals

THURAU, S. R., Chan, C.-C., Nussenblatt, R. B., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4571356.x · Cited by 149 · see citing works

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]

Hervé, P., Wijdenes, J., Jp, B., et al. (1990) · Blood · doi:10.1182/blood.v75.4.1017.1017 · Cited by 146 · see citing works

Development and Basic Mechanisms of Human Gut Immunity

Brandtzæg, P. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01645.x · Cited by 143 · see citing works

IL-4 and IL-10 Are Both Required for the Induction of Oral Tolerance

Rizzo, L. V., Morawetz, R. A., Miller-Rivero, N. E., Choi, R., Wiggert, B. O., Chan, C., Morse, H. C., Nussenblatt, R. B., & Caspi, R. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2613 · Cited by 117 · see citing works

Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.

Rizzo, L. V., Miller-Rivero, N. E., Chan, C. C., et al. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117511 · Cited by 109 · see citing works

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.

Brown, P. S., Parenteau, G. L., Dirbas, F. M., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2663 · Cited by 103 · see citing works

T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen

Benson, J., Campbell, K., Guan, Z., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10738 · Cited by 84 · see citing works

Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases

Guex‐Crosier, Y., Raber, J. M., Chan, C., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.452 · Cited by 70 · see citing works

Oral Administration of Myelin Basic Protein Is Superior to Myelin in Suppressing Established Relapsing Experimental Autoimmune Encephalomyelitis

Benson, J., Stuckman, S. S., Cox, K. L., Wardrop, R. M., Gienapp, I. E., Cross, A. H., Trotter, J. L., & Whitacre, C. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6247 · Cited by 70 · see citing works

PROLONGATION OF PRIMATE RENAL ALLOGRAFT SURVIVAL BY ANTI-TAC, AN ANTI-HUMAN IL-2 RECEPTOR MONOCLONAL ANTIBODY

Reed, M. H., SHAPIRO, M. E., Strom, T. B., et al. (1989) · Transplantation · doi:10.1097/00007890-198901000-00013 · Cited by 64 · see citing works

Heterologous epitopes of IRBP protect against autoimmune uveitis induced by the autologous epitope

Silver, P. B., Rizzo, L. V., Sun, B., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00111-8 · Cited by 9 · see citing works

Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)

Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163 · see citing works

588 POSTER Bench to bedside – Bedside to bench: Preclinical determination of the potential pharmacological activities of vandetanib in the clinic

Ryan, A. J., Odedra, R., James, N., et al. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)72522-9

心不全とサイトカイン : TNF-α過剰発現マウスを用いて(循環器教育セッションII循環器のbench to bedside, bedside to bench)

徹, 久. (2001) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.8.supple_50

心臓とサイトカイン : サイトカインの研究は心疾患の診断・治療に役立つか? (循環器教育セッションII循環器のbench to bedside, bedside to bench)

昭, 松. (2001) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.8.supple_43

冠動脈生検組織における蛋白・遺伝子発現(循環器教育セッションII循環器のbench to bedside, bedside to bench)

真喜子, 上. (2001) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.8.supple_38

Traumatic Brain Injury: From Bench to Bedside to Society

Chen, A. J.-W., & D’Esposito, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.041 · Cited by 5 · see citing works